BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  2 min read
• Press Releases

  Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  4 min read
• Press Releases

  Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 13, 2024

  December 16, 2024

   · 

  2 min read
• Press Releases

  Edesa Biotech Reports Fiscal Year 2024 Results

  December 16, 2024

   · 

  9 min read
• Press Releases

  Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024

  December 16, 2024

   · 

  4 min read
• Press Releases

  Neurocrine Biosciences Announces FDA Approval of CRENESSITY™ (crinecerfont), a First-in-Class Treatment for Children and Adults With Classic Congenital Adrenal Hyperplasia

  December 16, 2024

   · 

  15 min read
• Press Releases

  Pharming announces public cash offer to the shareholders of Abliva AB

  December 16, 2024

   · 

  10 min read
• Press Releases

  Celltrion Receives Positive CHMP Opinion for Three Biosimilars in the European Union

  December 16, 2024

   · 

  11 min read
• Press Releases

  Protheragen-ING Releases Hundreds of APIs: Anti-Tumor APIs, Hypoglycemic APIs, Antipsychotic APIs, Bronchiectasis APIs, Antihypertensive APIs

  December 16, 2024

   · 

  1 min read
• Press Releases

  Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

  December 16, 2024

   · 

  6 min read